AS620 - (PanScan 4) Whole Genome Scan for Pancreatic Cancer Risk
Cohort Consortium (PANSCAN)
Investigator Names and Contact Information
Laufey Amundadottir (amundadottirl@mail.nih.gov)
Rachael Stolzenberg-Solomon
Introduction/Intent
AS620 is Phase 4 of M4
Specific Aims
To conduct a GWAS study of pancreatic cancer by genotyping approximately 1,600 recently identified incident pancreatic cancer cases and controls with previous GWAS data drawn from cohort studies of the NCI cohort consortium.
- Using a joint analysis of these and PanScan 1 and 2 data, we will identify novel regions of the genome associated with pancreatic cancer susceptibility. As needed, we will participate with the Pancreatic Cancer Case-Control Consortium (PanC4) for replication of findings
- The genotype results and executive summaries of individual SNP analyses will be made available to bonafide researchers through a restricted-access website within several months of completion and following assessment of quality control.